Yes, mold can cause sepsis, but it happens almost exclusively in people with severely weakened immune systems. For the vast majority of healthy adults, inhaling mold spores produces no harmful effects at all. When mold does invade the body and reach the bloodstream, however, the resulting sepsis is extremely dangerous, with mortality rates that can exceed 85% for certain types of invasive mold infections.
How Mold Leads to Sepsis
Sepsis from mold follows a different path than the bacterial sepsis most people are familiar with. It starts when mold spores, which are microscopic and constantly floating in the air, enter the body through the lungs, sinuses, or breaks in the skin. In a healthy person, immune cells quickly destroy these spores before they can do any harm. In someone whose immune defenses are compromised, the spores can germinate and grow thread-like structures called hyphae that penetrate tissue and eventually reach the bloodstream.
Once mold enters the blood, it can spread to virtually any organ: the brain, kidneys, liver, heart, and skin. The body’s immune system launches a massive inflammatory response trying to fight the infection, and that response itself becomes part of the problem. Blood pressure drops, organs begin to fail, and the condition progresses to what clinicians recognize as fulminant sepsis. In one documented case of disseminated Aspergillus infection in a young man, the fungus spread to the gastrointestinal tract, lungs, kidneys, liver, eyes, and skin before causing fatal shock.
Who Is Actually at Risk
Invasive mold infections that lead to sepsis are overwhelmingly concentrated in specific populations. The people at highest risk include those with:
- Severely low white blood cell counts (neutropenia), often from chemotherapy
- Blood cancers such as leukemia or lymphoma
- Organ or stem cell transplants requiring long-term immune suppression
- Uncontrolled diabetes, particularly when it causes metabolic acidosis
- HIV/AIDS with advanced immune suppression
- Long-term corticosteroid use at high doses
- Severe burns or major trauma that breach the skin barrier extensively
Some rare inherited immune conditions also create vulnerability. People born with deficiencies in certain immune signaling proteins are prone to severe fungal infections throughout their lives. Patients in intensive care units on broad-spectrum antibiotics face additional risk because antibiotics kill competing bacteria, giving fungi room to grow unchecked.
If you’re generally healthy with a functioning immune system, household mold exposure is not going to cause sepsis. The CDC notes that most people, including many with weakened immune systems, inhale mold spores without any negative health effects. Mold in your home can certainly trigger allergies, asthma flares, and respiratory irritation, but the leap from environmental exposure to bloodstream infection requires a significant breakdown in immune function.
Which Molds Are Most Dangerous
The mold species most commonly responsible for invasive infections and fungal sepsis is Aspergillus, particularly the species A. fumigatus. Over 2.1 million people worldwide develop invasive aspergillosis each year, and the crude annual mortality is staggering: roughly 1.8 million deaths, reflecting how often this infection strikes people who are already critically ill. Aspergillus is everywhere in the environment, in soil, decaying vegetation, and indoor dust, which is why immune status rather than exposure level determines who gets sick.
Other mold species that cause invasive disease include Mucor and Rhizopus (the fungi behind mucormycosis, which gained attention during the COVID-19 pandemic), and Fusarium. Yeast-type fungi like Candida, which naturally live on skin and in the gut, are actually more common causes of fungal sepsis overall. In one large hospital dataset of over 170,000 patient encounters, about 6.3% of culture-positive infections were fungal, compared to 25.6% bacterial. Fungal sepsis is far less common than bacterial sepsis, but it carries higher mortality.
What About Black Mold?
Stachybotrys chartarum, the “black mold” that dominates public concern about household mold, has not been shown to cause invasive infections or sepsis in humans. A comprehensive review in Clinical Microbiology Reviews found no well-substantiated evidence of serious illness from Stachybotrys exposure in typical indoor environments. In laboratory experiments, injecting the fungus into animals caused only a local response with no systemic invasion. Black mold can produce toxins that irritate airways, but it does not behave like the molds that invade tissue and enter the bloodstream.
Warning Signs of Invasive Mold Infection
The early symptoms of an invasive mold infection are frustratingly nonspecific, which is part of what makes these infections so deadly. Persistent fever that doesn’t respond to antibiotics is often the first red flag, especially in someone with a known immune deficiency. Chest pain, cough, and shortness of breath are common when the lungs are involved, which they usually are since that’s where spores land first.
As the infection spreads, symptoms depend on which organs are affected. Gastrointestinal involvement can cause abdominal pain, bloody diarrhea, and vomiting. Skin lesions may appear as a spreading rash or darkened, necrotic patches. Eye redness with discharge, mouth sores, headaches, and rapid weight loss can all signal disseminated disease. The progression from localized infection to sepsis can happen over days to weeks, and by the time it’s recognized, patients are often critically ill with signs of organ failure: low blood pressure, rapid breathing, jaundice, and declining kidney function.
How Fungal Sepsis Is Detected
Diagnosing fungal sepsis is harder than diagnosing bacterial sepsis. Standard blood cultures, which reliably catch most bacteria, are much less sensitive for mold. Aspergillus, for instance, rarely grows in blood culture bottles even when it’s actively circulating in the bloodstream.
Doctors rely on a combination of approaches. Blood tests can detect molecules shed by fungal cell walls. One widely used test detects a sugar molecule called beta-D-glucan, which is present in the cell walls of most fungi. Its accuracy varies considerably depending on the specific test kit: sensitivity ranges from 27% to 100% and specificity from 0% to 100% across different commercial versions. For Candida infections specifically, estimated sensitivity is around 81% with specificity of 64%, meaning false positives and missed cases both occur. A second blood marker called galactomannan is more specific to Aspergillus. Tissue biopsy, where a sample is examined under a microscope for fungal structures, remains the most definitive way to confirm invasive mold disease but isn’t always feasible in critically ill patients.
Treatment and Survival
Treating mold-related sepsis requires aggressive antifungal medications, and the specific drug depends on the mold involved. For invasive aspergillosis, a class of antifungal drugs called triazoles is the standard first-line treatment. For patients with blood cancers and dangerously low white blood cell counts, a different antifungal delivered intravenously tends to be more effective, particularly a formulation designed to minimize kidney damage in patients who are already critically ill. Some cases call for combination therapy using two different antifungal drug classes simultaneously.
Even with appropriate treatment, outcomes depend heavily on whether the patient’s immune system can recover. Someone whose white blood cell count rebounds after chemotherapy has a meaningfully better chance than someone whose immune suppression is permanent. Treatment courses are long, often lasting weeks to months, and patients typically need close monitoring for relapse. The overall mortality for invasive aspergillosis remains extremely high, reflecting both the severity of the infection and the fragile health of the people it strikes.
For mucormycosis, surgical removal of infected tissue is often necessary alongside antifungal drugs, because these fungi invade blood vessels and cut off circulation to surrounding tissue, creating dead zones where medications can’t penetrate.